MK-677 for muscle gains: what the gym crowd gets wrong

What did @liftsbyfahd actually say?

Six days into a self-reported four-week MK-677 cycle at 15mg nightly, the creator showed a physique update and described what he was experiencing firsthand. He acknowledged the tradeoffs honestly: "muscles are looking a lot fuller" but also noted "abs are kind of gone" and that he looks "a lot more bloated." Sleep was good for him personally, though his friend had inconsistent results, sleeping well one night and poorly the next. He predicted that week two is "really when it picks up" in terms of hunger and recovery. No wild performance claims, no before-and-after transformation promises. Just a running diary of early-stage effects.

Worth noting: he's self-administering a research compound with no mention of medical oversight, bloodwork, or baseline testing. That context matters a lot and was absent from the video entirely.

Does the science back this up?

Mostly, yes, with some important caveats. MK-677 (ibutamoren) is a ghrelin receptor agonist that stimulates growth hormone and IGF-1 secretion. The fuller muscle appearance and water retention he described are well-documented and mechanistically expected effects. The sleep improvement he reported also has real support in the literature.

A randomized, double-blind trial by Copinschi et al. (1997, Sleep) found that MK-677 significantly increased REM sleep duration and overall sleep quality in healthy older adults. The mechanism is tied to growth hormone's role in slow-wave and REM architecture. His friend's inconsistent sleep response is also plausible. Nass et al. (2008, Journal of Clinical Endocrinology and Metabolism) noted significant interindividual variability in GH pulse responses to ibutamoren, which could reasonably translate to variable sleep effects.

The water retention and reduced definition he described align with what elevated IGF-1 and GH do to fluid regulation. This is not a side effect unique to MK-677. It is a direct pharmacological consequence of what the compound does.

What did they get wrong (or right)?

He got the water retention and fullness tradeoff right, and he deserves credit for saying it plainly rather than pretending MK-677 is a side-effect-free muscle builder. A lot of gym content skips that entirely.

Where things get shakier is the claim that week two is "really when it picks up" for hunger and recovery. Hunger escalation is plausible. Ghrelin receptor activation is literally the mechanism of action, and appetite stimulation is one of MK-677's most consistent documented effects across studies. Recovery benefits being meaningfully felt at the two-week mark is harder to support with current evidence. Studies on MK-677's effects on lean mass and recovery markers typically run eight weeks or longer. Murphy et al. (1998, Journal of Clinical Endocrinology and Metabolism) used a two-month protocol before observing significant lean mass changes. A one-to-two week window producing noticeable recovery enhancement is plausible in theory but is not well-documented in human trials.

He also implies the four-week cycle is low-risk because it is short. That framing glosses over real concerns. Blood glucose dysregulation and elevated cortisol are documented even in short-term use, per Copinschi et al. (1997). No mention of monitoring either.

What should you actually know?

MK-677 is not approved by the FDA for any medical use. It is classified as a research compound. That distinction is not a technicality. It means there is no standardized dosing, no regulatory quality control on what you are actually buying, and no long-term human safety data beyond a handful of small trials.

The short-term effects he described, water retention, sleep changes, appetite increases, are real and pharmacologically consistent. But the absence of side effects at day six does not tell you much. Blood glucose elevation is a documented concern with prolonged use. Nass et al. (2008) found that sustained GH and IGF-1 elevations from ibutamoren were associated with increased fasting glucose and insulin resistance in older adults. Younger users may have more metabolic buffer, but that has not been systematically studied.

If you are curious about peptide-based approaches to recovery, sleep, or body composition, the right starting point is a conversation with a licensed clinician who can assess your baseline and track relevant biomarkers, not a six-day TikTok diary, however honest it might be.